Pontifax Credit

Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management. They seek transformative, cutting-edge life sciences technologies at all development stages. Their portfolio comprises about 100 companies that develop breakthrough solutions to substantial unmet needs. They invest in early-stage and growth-stage companies across the healthcare sector, with a primary focus on life sciences, including biotechnology, pharmaceuticals, and medical devices. They invest in companies that are developing novel therapies for a wide range of diseases, including cancer, rare genetic disorders, and autoimmune diseases.